"This study highlights the potential for recommending a single dose for previously infected individuals and may be useful for discussions surrounding vaccination strategy," the researchers said.
Britain launched its inoculation drive with the US-German vaccine on December 8, with the United States, Canada and EU countries following suit.
Manama did not specify when it would begin the rollout of the vaccine by US pharmaceuticals giant Pfizer and its German partner BioNTech.
